Leaf has assisted Cerba Research to set up a Strategic Joint Venture with ACT Genomics

Author: BenCham Shanghai

Leaf - Law Firm has assisted Cerba Research to join forces with ACT Genomics under a joint venture model to create a purpose-built lab facility in Taiwan  covering the Asia Pacific Region.

Cerba Research is a leading global clinical trial laboratory services organization owned by Cerba HealthCare. This expansion of the precision medicine offering includes central labs, flow cytometry, histopathology, and translational science laboratory services.

Leaf has assisted Cerba Research in the drafting of the contractual documentation, structuring and negotation of this cross-border transaction between Europe and Asia.

You can read the entire press release here.